⌘K

Login Start Free

Home/Filings/4/0000897069-25-000789

4//SEC Filing

Bigora Sian 4

Accession 0000897069-25-000789

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 5:17 PM ET

Size

6.5 KB

Accession

0000897069-25-000789

Insider Transaction Report

Form 4

Period: 2025-04-11

Processa Pharmaceuticals, Inc.PCSA

Chief Development Officer

Transactions

Tax Payment
Common Stock
2025-04-01$0.41/sh−3,311$1,364→ 33,626 total
Exercise/Conversion
Common Stock
2025-04-01+15,059→ 36,937 total

Holdings

Common Stock
(indirect: By LLC)
6,668

Footnotes (1)

[F1]Distribution of vested restricted shares.

Documents

1 file

4
form4.xmlPrimary

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001799365

Filing Metadata

Form type: 4
Filed: Apr 10, 8:00 PM ET
Accepted: Apr 11, 5:17 PM ET
Size: 6.5 KB

View on SEC.gov